Isabelle Ravelingien

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial

Frédéric Houssiau, David D’Cruz, Shirish Sangle et al. · Annals of the Rheumatic Diseases · 2010 · 496 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis

Farah Tamirou, David D’Cruz, Shirish Sangle et al. · Annals of the Rheumatic Diseases · 2015 · 208 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial

Patrick Verschueren, Diederik De Cock, Luk Corluy et al. · Annals of the Rheumatic Diseases · 2014 · 129 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial

Patrick Verschueren, Diederik De Cock, Luk Corluy et al. · Annals of the Rheumatic Diseases · 2016 · 114 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA

Veerle Stouten, René Westhovens, Sofia Pazmiño et al. · Lara D. Veeken · 2019 · 64 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16